Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Treating KRAS-Mutated mCRC

Ibrahim Sahin

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

ASCO® GI 2024 Panel Discussion: "ctDNA in Colon Cancer - GALAXY, BES…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

Year in Review: ctDNA in Colorectal Cancer

Weill Cornell Medicine Oncology & Hematology

P. Kasi

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cance…

2024 ASCO® Annual Meeting Insights Hub

S. Chakrabarti, A. Shreenivas

Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Col…

Scripps Health

S. Cohen

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi